2020
Where will telemedicine go from here?
Rotker K, Velez D. Where will telemedicine go from here? Fertility And Sterility 2020, 114: 1135-1139. PMID: 33280718, PMCID: PMC9135996, DOI: 10.1016/j.fertnstert.2020.10.050.Peer-Reviewed Original ResearchConceptsPerson visitsCOVID-19 pandemicElectronic medical recordsAdoption of telemedicinePhysical examinationMedical recordsTelehealth appointmentsSurgical volumePhysical distancing guidelinesTelehealth platformPatient careSemen testingReproductive clinicSafe methodPatientsTelehealthVisitsClinical trainingTelemedicineMedical studentsSupport staffPandemicClinicGender Disparities in Industry Payments to Urologists
Velez D, Mehta A, Rotker K, Thavaseelan S. Gender Disparities in Industry Payments to Urologists. Urology 2020, 150: 59-64. PMID: 32569655, DOI: 10.1016/j.urology.2020.05.074.Peer-Reviewed Original Research
2019
Addressing patient gender bias toward trainees in the field of andrology
Rotker K, Thavaseelan S, Sigman M. Addressing patient gender bias toward trainees in the field of andrology. Fertility And Sterility 2019, 112: 640-641. PMID: 31561867, DOI: 10.1016/j.fertnstert.2019.08.003.Peer-Reviewed Original Research
2018
What's Gender Got to Do With It: Difference in the Proportion of Traditionally Female Cases Performed by General Urologists of Each Gender
Rotker K, Iosifescu S, Baird G, Thavaseelan S, Hwang K. What's Gender Got to Do With It: Difference in the Proportion of Traditionally Female Cases Performed by General Urologists of Each Gender. Urology 2018, 116: 35-40. PMID: 29550347, DOI: 10.1016/j.urology.2017.12.040.Peer-Reviewed Original ResearchMeSH KeywordsCareer ChoiceCatchment Area, HealthCertificationFemaleGender IdentityGynecologic Surgical ProceduresHumansLogistic ModelsMalePatient PreferencePhysicians, WomenPopulation DensityPractice Patterns, Physicians'Referral and ConsultationUnited StatesUrologic Surgical ProceduresUrologistsUrologyConceptsGeneral urologistsTotal casesCPT codesCurrent Procedural Terminology codesLogistic regression analysis modelProcedural Terminology codesCase log dataPatient populationUrogynecologic proceduresPractice patternsFemale casesTerminology codesUrologistsRegression analysis modelSignificant differencesGreater percentageAmerican BoardCertification periodUnproven hypothesisPercentageGenderMale counterpartsCases
2017
Association of subcutaneous testosterone pellet therapy with developing secondary polycythemia
Rotker KL, Alavian M, Nelson B, Baird GL, Miner MM, Sigman M, Hwang K. Association of subcutaneous testosterone pellet therapy with developing secondary polycythemia. Asian Journal Of Andrology 2017, 20: 195-199. PMID: 29205178, PMCID: PMC5858107, DOI: 10.4103/aja.aja_51_17.Peer-Reviewed Original ResearchConceptsTestosterone replacement therapyDevelopment of polycythemiaSecondary polycythemiaRetrospective chart reviewChart reviewMedian timeTestosterone pelletsReplacement therapyAdministration modalitiesExogenous testosteroneInstitutional reviewPolycythemiaTherapyMonthsMean numberHigh ratePotential riskRiskT pelletsPatientsReviewTestosteroneEfficacy of Standardized Nursing Fertility Counseling on Sperm Banking Rates in Cancer Patients
Rotker K, Vigneswaran H, Omil-Lima D, Sigman M, Hwang K. Efficacy of Standardized Nursing Fertility Counseling on Sperm Banking Rates in Cancer Patients. Urology 2017, 104: 90-96. PMID: 28267604, DOI: 10.1016/j.urology.2017.01.041.Peer-Reviewed Original ResearchConceptsInitiation of chemotherapyFertility counselingSperm bankingCancer patientsInstitution BInstitution ARetrospective chart reviewChart reviewYounger patientsMale patientsNurse counselingPatientsChemotherapyEducation sessionsCounseling sessionsCounselingCounseling programInitiationSessionsCancerAdditional analysesRate
2016
Upgrading and upstaging at radical prostatectomy in the post–prostate-specific antigen screening era: an effect of delayed diagnosis or a shift in patient selection?
Edmund L, Rotker KL, Lakis NS, Brito JM, Lepe M, Lombardo KA, Renzulli JF, Matoso A. Upgrading and upstaging at radical prostatectomy in the post–prostate-specific antigen screening era: an effect of delayed diagnosis or a shift in patient selection? Human Pathology 2016, 59: 87-93. PMID: 27720731, DOI: 10.1016/j.humpath.2016.09.017.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overBiopsy, NeedleCytoreduction Surgical ProceduresDelayed DiagnosisEarly Detection of CancerHumansKallikreinsMaleMiddle AgedNeoplasm GradingNeoplasm StagingPatient SelectionPredictive Value of TestsProstatectomyProstate-Specific AntigenProstatic NeoplasmsTime FactorsWatchful WaitingConceptsGroup 2Group 1Group 3Needle biopsyActive surveillanceProstate-specific antigen (PSA) screeningPathologic stage pT3Radical prostatectomy findingsLow-risk diseaseGleason score 4High-risk diseaseGleason score 8Prostate needle biopsyProstate cancer managementProstatectomy findingsCytoreductive surgeryStage pT3Screening eraMore patientsPatient selectionAntigen screeningScore 8Radical prostatectomyGleason 6Cancer managementRecurrent varicocele
Rotker K, Sigman M. Recurrent varicocele. Asian Journal Of Andrology 2016, 18: 229-233. PMID: 26806078, PMCID: PMC4770491, DOI: 10.4103/1008-682x.171578.Peer-Reviewed Original Research
2015
Atypical small acinar proliferation (ASAP): Is a repeat biopsy necessary ASAP? A multi-institutional review
Leone A, Gershman B, Rotker K, Butler C, Fantasia J, Miller A, Afiadata A, Amin A, Zhou A, Jiang Z, Sebo T, Mega A, Schiff S, Pareek G, Golijanin D, Yates J, Karnes RJ, Renzulli J. Atypical small acinar proliferation (ASAP): Is a repeat biopsy necessary ASAP? A multi-institutional review. Prostate Cancer And Prostatic Diseases 2015, 19: 68-71. PMID: 26857145, DOI: 10.1038/pcan.2015.52.Peer-Reviewed Original ResearchConceptsAtypical small acinar proliferationHigh-grade prostate cancerImmediate repeat biopsySmall acinar proliferationMulti-institutional reviewRepeat biopsySubsequent prostate cancerProstate cancerAcinar proliferationInitial diagnosisProstate biopsyRetrospective multi-institutional reviewAbnormal digital rectal examTransrectal ultrasound-guided biopsyPre-biopsy PSAHigh-grade diseaseDigital rectal examUltrasound-guided biopsyUnderwent repeat biopsyMajority of menElevated PSAGleason 7Clinicopathologic featuresRectal examHigher PSA
2013
The Impact of Obesity on Benign and Malignant Urologic Conditions
Chu KF, Rotker K, Ellsworth P. The Impact of Obesity on Benign and Malignant Urologic Conditions. Postgraduate Medicine 2013, 125: 53-69. PMID: 23933894, DOI: 10.3810/pgm.2013.07.2679.Peer-Reviewed Original ResearchConceptsMalignant urologic conditionsObesity/MetSUrologic conditionsLower urinary tract symptomsUnfavorable lipid levelsCardiac risk factorsUrinary tract symptomsEffect of obesityImpact of obesityPrevalence of obesityBody mass indexRenal cell cancerBenign prostatic hyperplasiaMale sexual functionUrologic disease processesAtherogenic dyslipidemiaLifestyle modificationTract symptomsVisceral obesityEndothelial dysfunctionMale hypogonadismObese patientsSystemic inflammationMetabolic syndromeCell cancer